Details of the Drug

General Information of Drug (ID: DM9BX64)

Drug Name

KAZ954

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04237649) KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors. U.S. National Institutes of Health.